BPPI sales turnover up 94 percent to Rs 146.59 crore in Q1
New Delhi: The Bureau Of Pharma PSUs Of India (BPPI) reported a 94.21 percent increase in its sales turnover at Rs 146.59 crore for the quarter ended June 30, 2020, the Ministry of Chemicals and Fertilizers said on Sunday.It had posted a sales turnover of Rs 75.48 crore in the corresponding first quarter of previous fiscal year, a statement by the ministry said.BPPI is the implementing agency...
New Delhi: The Bureau Of Pharma PSUs Of India (BPPI) reported a 94.21 percent increase in its sales turnover at Rs 146.59 crore for the quarter ended June 30, 2020, the Ministry of Chemicals and Fertilizers said on Sunday.
It had posted a sales turnover of Rs 75.48 crore in the corresponding first quarter of previous fiscal year, a statement by the ministry said.
BPPI is the implementing agency for Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
The Janaushadhi Kendras remained functional during the lockdown as part of their commitment to ensure uninterrupted availability of essential medicines to the people, the statement said.
Read also: Jubilant Life Sciences Q1 PAT down 52 pc at Rs 88 crore
"Present basket of medicines sold by these Kendras consists of 1,250 medicines and 204 surgical instruments. The target is set to enhance it to up to 2,000 medicines and 300 surgical products by the end of March 31, 2024...," it added.
BPPI was established in December 2008 under the Department of Pharmaceuticals.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd